Nascent Trader Blog | Talkmarkets | Page 1
Fundamental Investor

My name is Xipu Li. I am a full-time student at Gabelli School of Business at Fordham University. I focus on on fundamentals, long/short and equity research. My passions outside of investing and school include cars, steak and wine, photography, soccer, meditation, and tea. I am a contributor to ... more

All Contributions

Latest Posts
1 to 2 of 2 Posts
New Hope For Acorda Therapeutics In 2019
I recommend long Acorda Therapeutics (ACOR) for 1-3 months aiming at a price target zone ranging from $20.23-$27.24 (currently trading at $15.95). The negative impact of generics erosion on Ampyra's sales has been overstated in my opinion.
Starbucks: A Good Candidate For Value Investors
Despite the lower-than-expected earnings report in April 2017, Starbucks is still the largest coffee shop chain in the world and is likely undervalued. Ben Graham's criteria for defensive investors suggests Starbucks is a somewhat good pick.
1 to 2 of 2 Posts